Clinical Trial Update: A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding

View source ↗

Summary

Global multicenter clinical trial update evaluating maternal, fetal, and infant outcomes after exposure to Palynziq (pegvaliase) during pregnancy and breastfeed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• PALYNZIQ (PEGVALIASE-PQPZ)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria, Maternal | Status: RECRUITING